Related Experiment Videos
[Multiple thromboembolism associated with anti-thrombin III deficiency]
C Catarino1, P M Silva, J Quininha
1Serviços de Cardiologia, Hospital de Santa Marta, Lisboa.
Acta Medica Portuguesa
|May 1, 1991
Summary
Congenital antithrombin III deficiency is a primary hypercoagulable state. This case highlights the importance of investigating thrombophilia in patients with recurrent arterial and venous thrombosis.
Area of Science:
- Cardiology
- Hematology
- Genetics
Background:
- Congenital antithrombin III deficiency is a rare inherited thrombophilia.
- It significantly increases the risk of venous and arterial thromboembolism.
- Aortic valve disease can be associated with thromboembolic complications.
Observation:
- A 28-year-old male presented with aortic valve disease and multiple thromboembolic events.
- The patient was diagnosed with congenital antithrombin III deficiency.
- This case illustrates a complex interplay between genetic predisposition and cardiovascular pathology.
Findings:
- Congenital antithrombin III deficiency was confirmed as the underlying cause of recurrent thrombosis.
- The patient experienced both venous and arterial thromboembolic events.
- Diagnostic and therapeutic challenges in managing such cases were discussed.
Implications:
- Early diagnosis of antithrombin III deficiency is crucial for preventing severe thrombotic events.
- Thrombophilia screening should be considered in young individuals with unexplained recurrent thrombosis.
- Integrated management of genetic and cardiovascular conditions is essential for optimal patient outcomes.